pharmacology Flashcards

1
Q

phase 4

A

resting potential outward flux of K is dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

phase 0

A

upstroke, inward flux of Na is dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

phase 1

A

early repolarisation, outward flux of K is dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

phase 2

A

plateau, inward flux of Ca2+ is roughly balanced by outward flux of K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

phase 3

A

final repolarisation, outward flux of K is dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

sympathetic regulation of cardiac rate and force

A

noradrenaline and adrenaline activate beta 1 adrenoceptors in nodal and myocardial cells
coupling through G protein alpha subunit stimulates adenylyl cyclase to increase the intracellular concentration of cyclic AMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

parasympathetic regulation of cardiac rate and force

A

acetylcholine activates M2 muscarinic cholinoreceptors largely in nodal cells
coupling through G protein via alpha subunits inhibits cyclase and reduces cAMP, via beta/gamma subunit dimer opens specific potassium channels in the SA node
decreased SA node action potential frequency and heart rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

funny current

A

depolarising current, blocked HCN channels in SA ode slows heart rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

excitation contraction coupling in cardiac muscle - contraction

A

ventricular action potential
opening of voltage actived Ca2+ channels during phase 2
Ca2+ influx into cytoplasm
Ca2+ release from the sacroplasmic reticulum
Ca2+ binds to troponin C and shifts tropomyosin out of the actin cleft
cross bridge formation between actin and myosin resulting in contraction via the sliding filament mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

excitation contraction coupling in cardiac muscle - relaxation

A

repolarisation in phase 3 and 4
voltage activated Ca2+ channels close
Ca2+ efflux occurs by the Na/Ca exchanger
Ca2+ release from the sarcoplasmic reticulum stops, active sequestration of Ca2+ from the cytoplasm now dominates
Ca2+ dissociates from troponin C
cross bridges between actin and myosin break resulting in relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

nitrates

A

organic nitrates relax all smooth muscle via their metabolism to nitric oxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

calcium channel blockers

A

block or prevent opening of channels in excitable tissues in response to depolarisation and limit increase of Ca, causes vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

haemostasis

A

arrest of blood loss form a damaged vessel at the site of injury involves a sequence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

primary haemostasis

A

local vasoconstriction, platelet adhesion, activation and aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

inactive factors

A

X

II - prothrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

active factor

A

IXa
Xa
IIa - thrombin

17
Q

active cofactor

A

VIIIa

Va

18
Q

arterial thrombus

A

white thrombus - mainly platelets in a fibrin mesh
forms an embolus if it detaches often causes a stroke
primary treatment is antiplatelet drugs

19
Q

venous thrombus

A

red thrombus - white head, jelly like red tail fibrin rich
embolus usually in the lung
primary treatment is anticoagulant

20
Q

rivaroxiban

A

directly inhibits factor Xa

21
Q

LMWH and fondaparinux

A

inactivate foactor Xa via antithrombin III

22
Q

Dabigatran

A

directly inhibits factor IIa

23
Q

heparin

A

inactivates factor IIa via antithrombin III

24
Q

warfarin

A

structurally related to vitamin K with which it competes for binding to hepatic vitamin K reductase preventing production of the active hydroquinone
renders factors II, VII, IX and X inactive
slow onset
low therapeutic index
long half life 40 hours